News

BATMAN brings T cell receptor therapy out of the shadows
Imagine your immune cells could be modified to attack any kind of cancer. T cell receptor (TCR) therapy has the potential to ...
AI-designed T cell receptor substitutes can accelerate precision cancer immunotherapy
New designer proteins created using an AI tool can selectively target peptide segments that bind to markers on diseased ...
BATMAN brings TCR therapy out of the shadows
Imagine your immune cells could be modified to attack any kind of cancer. T cell receptor (TCR) therapy has the potential to ...
Fierce Biotech5d
AstraZeneca drops lead T-cell receptor therapy from $200M Neogene buy
AstraZeneca has dropped the lead candidate from its $200 million buyout of Neogene Therapeutics as part of a wider cell ...
MaxCyte Announces Strategic Platform Licensing Agreement with Anocca AB to Advance TCR-T Cell Therapy Pipeline
MaxCyte’s Flow Electroporation® Technology will support non-viral gene editing in the manufacture of Anocca’s TCR-T cell therapiesROCKVILLE, Md., July 31, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., ...
The Scientist9d
BATMAN Signals T Cell Receptor Crossreactivity
A new AI tool that models how variations in peptides change T cell receptor binding could help design immunotherapies with ...
Labroots3d
Doctors Identify a Case of HPV-Driven Skin Cancer
A case report recently published in the New England Journal of Medicine (NEJM) presents a previously unknown cause of skin ...
Fred Hutchinson Cancer Center9d
‘Manufacturing scientist’ believes in the machinery that powers Fred Hutch’s cell therapies
Dr. Folashade Otegbeye, facility director of the Therapeutic Products Program at Fred Hutch, works to rapidly translate what ...
Techno-Science.net on MSN3d
🩺 Cancer: forgotten cells go on the offensive
Immunologists from UNIGE have discovered the previously unsuspected anti-tumor potential of CD4 T lymphocytes. An important ...